FDA Warns Investigator Over Records, Procedural Violations in Clinical Trial

Clinical Trials Advisor
A A
The FDA issued a warning letter to an Indianapolis doctor over her management of a clinical investigation for Pfizer.

To View This Article:

Login

Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $25.00